Australia markets closed

Homology Medicines Inc (35H.BE)

Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
14.13+13.35 (+1,700.00%)
As of 09:02AM CEST. Market open.
Full screen
Previous close0.79
Open0.79
Bid0.00 x 0
Ask0.00 x 0
Day's range0.79 - 14.13
52-week range0.79 - 19.50
Volume2,000
Avg. volume0
Market capN/A
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings date13 Mar 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • PR Newswire

    Q32 Bio Appoints Lee Kalowski as President & Chief Financial Officer

    Q32 Bio Inc. (NASDAQ: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing biologic therapeutics to restore immune homeostasis, today announced the appointment of Lee Kalowski as President and Chief Financial Officer. Mr. Kalowski brings over 20 years of biopharmaceutical experience with a focus on strategy, raising capital, and financial operations.

  • GlobeNewswire

    Homology Medicines Declares Distribution to Common Stockholders

    BEDFORD, Mass., March 18, 2024 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX) today announced that it declared a distribution to its common stockholders of record as of the close of business on March 21, 2024 of the right to receive one contingent value right (CVR) for each outstanding share of Homology common stock held by such stockholder as of such record date. The payment date for such distribution is expected to be March 27, 2024 (three business days after the expected closing

  • GlobeNewswire

    Homology Medicines Receives NASDAQ Notification Regarding Minimum Bid Price Deficiency

    Homology Medicines has an initial 180-day period through June 26, 2024 to regain compliance with Minimum Bid Price Requirement BEDFORD, Mass., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX) today announced that it received notification (“Nasdaq Notification”) from The Nasdaq Stock Market LLC (“Nasdaq”) on December 29, 2023 indicating that, for the last thirty (30) consecutive business days, the bid price for the Company’s common stock had closed below the minimum $1.00